Arcturus Therapeutics Holdings (ARCT) EBITDA Margin (QoQ) (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) EBITDA Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arcturus Therapeutics Holdings 217.14 Mn 5.76 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -90,420.00
Dec 31, 2025 -32,569.00
Sep 30, 2025 -4,597.00
Jun 30, 2025 1,547.00
Mar 31, 2025 8,389.00
Dec 31, 2024 -11,523.00
Sep 30, 2024 1,796.00
Jun 30, 2024 3,602.00
Mar 31, 2024 -3,261.00
Dec 31, 2023 -200.00
Sep 30, 2023 46,364.00
Jun 30, 2023 -56,279.00
Mar 31, 2023 -999.00
Dec 31, 2022 33,700.00
Sep 30, 2022 -18,420.00
Jun 30, 2022 89,617.00
Mar 31, 2022 -30,847.00
Dec 31, 2021 155,199.00
Sep 30, 2021 50,840.00
Jun 30, 2021 -7,860.00